Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
link
photo
Tags
cannabidiol
clinical trials
dravet syndrome
drugs
epidiolex
fda
fen-phen
fenfluramine
gw pharmaceuticals
lennox-gastaut syndrome
life sciences
national blog main
san francisco
san francisco blog main
san francisco top stories
zogenix
What
approved
2
×
cannabis
2
×
drug
epilepsy
2
×
accessibility
ago
approval
battle
cbd
currently
data
dea
derivative
epileptic
fast
fda
form
gw
gw’s
huge
impact
marijuana
market
medication
medicine
nationwide
patients
person
pharmaceuticals
rare
reschedule
schedule
sets
sold
tracked
treatment
use
weeks
writer's
zogenix
Language
Current search:
approved
×
epilepsy
×
cannabis
×
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug
@WIRED
6 years ago
Currently, CBD is a Schedule 1 drug like cannabis, and the DEA must reschedule it before the epilepsy medication can be sold. If approved, this would have ...